INJ PRICE ANALYSIS
Injective (INJ) Surges on EVM Testnet Launch Amid Bullish Momentum: Price Outlook and Key Insights
Injective (INJ) sees a 15% surge following the EVM testnet launch and bullish technical breakout. With a teased announcement on July 17, market sentiment remains high.
Injective (INJ) Gains Momentum: EVM Testnet, Partnerships, and Bullish Price Trends
Injective (INJ) surges with its EVM testnet launch, partnerships with Google Cloud and Deutsche Telekom, and a potential 3x rally. Here's what traders need to know.
Injective (INJ): EVM Testnet Launch, Strategic Partnerships, and Bullish Momentum in 2025
Injective (INJ) gains momentum with its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and bullish price action above $13.50.
Injective (INJ) Gains Momentum with EVM Testnet, Institutional ETF Filing, and Strategic Partnerships
Injective (INJ) pushes forward with bullish developments, including an EVM testnet launch, institutional ETF filing, and regulatory collaboration, signaling long-term growth prospects.
Injective (INJ) Rallies 15%: EVM Testnet Launch and Strategic Partnerships Drive Growth
Injective (INJ) surged 15% this week, fueled by its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and growing DeFi adoption.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships
Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Bullish Breakout
Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish technical momentum, INJ eyes $15+.